Evaluating FDA's Proposed Patient Medication Information Handout

NAActive, not recruitingINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

March 3, 2024

Primary Completion Date

March 4, 2024

Study Completion Date

March 3, 2025

Conditions
KnowledgeAttitude
Interventions
OTHER

FDA template PMI

Intervention is an information format viewed by participants. The patient medication information format was designed according to a proposed FDA template, which provides information about safe and effective use of a medication. No drug or device is included as part of this intervention.

OTHER

Decision Critical PMI

Intervention is an information format viewed by participants. The patient medication information format was designed according to a proposed FDA template and modified, according to decision science principles, to include benefit information, which provides information about safe and effective use of a medication. No drug or device is included as part of this intervention.

OTHER

Standard Information

The intervention is an information format viewed by participants. This patient medication information format is the current standard of care patient medication information that is included with the drug. No drug or device is included as part of this intervention.

Trial Locations (1)

15213

Carnegie Mellon University, Pittsburgh

All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

lead

Carnegie Mellon University

OTHER

NCT06320808 - Evaluating FDA's Proposed Patient Medication Information Handout | Biotech Hunter | Biotech Hunter